세계의 주사 치료 시장 - 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Rosacea treatment market size is poised to witness a 6.5% CAGR between 2024 and 2032 driven by the rising prevalence of rosacea. As awareness of rosacea increases, more individuals are seeking diagnoses and treatments, boosting the demand for effective therapies. Dermatological research advancements have made way for innovative treatments, spanning topical and oral medications, laser therapies, and advanced skincare products, all targeting diverse symptoms of rosacea.

Heightened research into the causes and triggers of rosacea has also birthed tailored treatments, that cater to individual patient needs. The surge in over-the-counter treatments, alongside new non-prescription products, addresses mild to moderate rosacea cases, broadening the market beyond traditional prescription therapies.

The overall industry is divided into type, treatment type, drug class, distribution channel, and region.

Based on type, the rosacea treatment market size from the ocular rosacea segment is anticipated to witness unprecedented growth through 2032 driven by the heightened awareness of its impact on eye health and the demand for specialized treatments. The discomfort of ocular rosacea also necessitates targeted therapies. This awareness has intensified the focus on developing treatments for eye-related rosacea symptoms.

With respect to distribution channel, the rosacea treatment market from the online pharmacies segment is predicted to record notable gains up to 2032. This is owing to the increased convenience and accessibility these settings offer for purchasing medications and skincare products. Online pharmacies also provide patients with a wide range of rosacea treatments, including prescription medications, over-the-counter products, and specialized skincare regimens, all available with the ease of home delivery.

Asia Pacific rosacea treatment industry size will grow significantly through 2032 attributed to urbanization, heightened awareness of dermatological issues, and the adoption of advanced skincare solutions. As dermatological health gains prominence, the demand for effective rosacea treatments surges. Bolstered by an expanding healthcare infrastructure and innovative treatments tailored to diverse skin types, the regional market will witness an upward trajectory.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of rosacea
    • 3.2.1.2 Advancements in combination therapies and drugs
    • 3.2.1.3 Rising awareness and diagnosis
    • 3.2.1.4 Improving access to diagnosis and treatment
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High treatment costs and availability of alternative treatment options
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Pipeline analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Erythematotelangiectatic rosacea
• 5.3 Papulopustular rosacea
• 5.4 Ocular rosacea
• 5.5 Phymatous rosacea

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oral
• 6.3 Topical
• 6.4 Other treatment types

Chapter 7 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Antibiotic
• 7.3 Alpha agonist
• 7.4 Retinoid
• 7.5 Corticosteroid
• 7.6 Immunosuppressant
• 7.7 Other drug classes

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital pharmacies
• 8.3 Retail pharmacies
• 8.4 Online pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Aclaris Therapeutics
• 10.2 Colorescience, Inc.
• 10.3 Croda International Plc
• 10.4 Dr. Reddy's Laboratories Ltd
• 10.5 Galderma
• 10.6 Journey Medical Corporation
• 10.7 Leopharma
• 10.8 Lupin
• 10.9 Maruho Co.,Ltd.
• 10.10 Merck and Co., Inc
• 10.11 Mylan N.V.
• 10.12 Perrigo Company plc
• 10.13 PRUGEN
• 10.14 Sol-Gel Technologies Ltd